Manel Esteller: Epigenetic Hallmarks of Cancer at Cancer Discovery AACR has made it to the “Most Read” list of the journal
Manel Esteller, Group Leader of Cancer Epigenetics at the Josep Carreras Institute, shared his recent article on X.
“Excited to learn that our Epigenetic Hallmarks of Cancer at Cancer Discovery American Association for Cancer Research has made it to the “Most Read” list of the journal !”
The Epigenetic Hallmarks of Cancer
Authors: Manel Esteller, et al.
Manel Esteller is the Group Leader of Cancer Epigenetics at the Josep Carreras Institute and serves as the Chairman of Genetics at the University of Barcelona’s School of Medicine. He is also an ICREA Research Professor. His current research focuses on mapping the epigenome and epitranscriptome of both normal and transformed cells, examining the interactions between epigenetic modifications and non-coding RNAs, and developing new epigenetic drugs for cancer therapy. Previously, Dr. Esteller directed the Cancer Epigenetics and Biology Program (PEBC) in Barcelona and led the Josep Carreras Leukaemia Research Institute (IJC).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023